Search Results

There are 11048 results for: content related to: The JR blood group system ( ISBT 032): molecular characterization of three new null alleles

  1. Molecular analysis of immunized Jr(a–) or Lan– patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a–) and Lan– phenotypes

    Transfusion

    Volume 54, Issue 7, July 2014, Pages: 1836–1846, Lonneke Haer-Wigman, Aïcha Ait Soussan, Peter Ligthart, Masja de Haas and C. Ellen van der Schoot

    Version of Record online : 24 JAN 2014, DOI: 10.1111/trf.12544

  2. A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a−) phenotype

    Transfusion

    Volume 55, Issue 6pt2, June 2015, Pages: 1467–1471, Kenichi Ogasawara, Takahiro Osabe, Yumi Suzuki, Hatsue Tsuneyama, Kazumi Isa, Miho Kawai, Kumi Obara, Yoshiko Ogiyama, Shoichi Ito, Makoto Uchikawa, Masahiro Satake and Kenji Tadokoro

    Version of Record online : 18 DEC 2014, DOI: 10.1111/trf.12969

  3. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells

    Molecular Carcinogenesis

    Volume 51, Issue 6, June 2012, Pages: 449–464, Kenneth K.W. To, Le Yu, Shuwen Liu, Jianhua Fu and Chi Hin Cho

    Version of Record online : 15 JUN 2011, DOI: 10.1002/mc.20810

  4. ABCG2: A New Challenge in Cancer Drug Resistance

    ABC Transporters and Multidrug Resistance

    Orsolya Polgar, Robert W. Robey, Kin Wah To, John Deeken, Patricia A. Fetsch, Susan E. Bates, Pages: 83–117, 2009

    Published Online : 15 JUN 2009, DOI: 10.1002/9780470495131.ch3

  5. Determination of functional ABCG2 activity and assessment of drug–ABCG2 interactions in dairy animals using a novel MDCKII in vitro model

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 2, February 2013, Pages: 772–784, Louise Wassermann, Sandra Halwachs, Stefan Lindner, Kerstin U. Honscha and Walther Honscha

    Version of Record online : 28 NOV 2012, DOI: 10.1002/jps.23399

  6. ABCG2 transporter: therapeutic and physiologic implications in veterinary species

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 35, Issue 2, April 2012, Pages: 105–112, K. L. MEALEY

    Version of Record online : 6 JUN 2011, DOI: 10.1111/j.1365-2885.2011.01313.x

  7. Defining the Jr(a–) phenotype in the Japanese population

    Transfusion

    Volume 54, Issue 2, February 2014, Pages: 412–417, Mitsunobu Tanaka, Ikuko Kamada, Junko Takahashi, Keiko Kimura, Harumichi Matsukura and Yoshihiko Tani

    Version of Record online : 29 MAY 2013, DOI: 10.1111/trf.12277

  8. You have free access to this content
    Regulation and Expression of the ATP-Binding Cassette Transporter ABCG2 in Human Embryonic Stem Cells

    STEM CELLS

    Volume 30, Issue 10, October 2012, Pages: 2175–2187, Raji Padmanabhan, Kevin G. Chen, Jean-Pierre Gillet, Misty Handley, Barbara S. Mallon, Rebecca S. Hamilton, Kyeyoon Park, Sudhir Varma, Michele G. Mehaffey, Pamela G. Robey, Ronald D. G. McKay and Michael M. Gottesman

    Version of Record online : 20 SEP 2012, DOI: 10.1002/stem.1195

  9. BCRP (ABCG2)

    Pharmacogenomics of Human Drug Transporters: Clinical Impacts

    Agnes Basseville, Susan E. Bates, William D. Figg, Alex Sparreboom, Pages: 311–343, 2013

    Published Online : 15 MAR 2013, DOI: 10.1002/9781118353240.ch14

  10. You have free access to this content
    Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer

    British Journal of Pharmacology

    Volume 172, Issue 16, August 2015, Pages: 4089–4106, Kenneth K W To, Daniel C Poon, Yuming Wei, Fang Wang, Ge Lin and Liwu Fu

    Version of Record online : 26 JUN 2015, DOI: 10.1111/bph.13189

  11. ABCG2 (BCRP) expression in normal and malignant hematopoietic cells

    Hematological Oncology

    Volume 21, Issue 3, September 2003, Pages: 115–130, Brian L. Abbott

    Version of Record online : 6 OCT 2003, DOI: 10.1002/hon.714

  12. You have free access to this content
    Abcg2 deficiency augments oxidative stress and cognitive deficits in Tg-SwDI transgenic mice

    Journal of Neurochemistry

    Volume 122, Issue 2, July 2012, Pages: 456–469, Yu Zeng, Debbie Callaghan, Huaqi Xiong, Ze Yang, Peilin Huang and Wandong Zhang

    Version of Record online : 6 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07783.x

  13. The JR blood group system: identification of alleles that alter expression

    Transfusion

    Volume 53, Issue 11, November 2013, Pages: 2710–2714, Kim Hue-Roye, Teresa Zelinski, Adam Cobaugh, Christine Lomas-Francis, Toru Miyazaki, Yoshihiko Tani, Connie M. Westhoff and Marion E. Reid

    Version of Record online : 25 FEB 2013, DOI: 10.1111/trf.12118

  14. You have full text access to this OnlineOpen article
    HIF-2α Suppresses p53 to Enhance the Stemness and Regenerative Potential of Human Embryonic Stem Cells

    STEM CELLS

    Volume 30, Issue 8, August 2012, Pages: 1685–1695, Bikul Das, Reza Bayat-Mokhtari, Micky Tsui, Shamim Lotfi, Rika Tsuchida, Dean W. Felsher and Herman Yeger

    Version of Record online : 24 JUL 2012, DOI: 10.1002/stem.1142

  15. Comparison of chemotherapeutic drug resistance in cells transfected with canine ABCG2 or feline ABCG2

    Veterinary and Comparative Oncology

    R. S. Lewis, J. Fidel, S. Dassanayake, M. H. Court, N. S. Burke and K. L. Mealey

    Version of Record online : 14 OCT 2015, DOI: 10.1111/vco.12177

  16. Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway

    ChemMedChem

    Volume 7, Issue 4, April 2012, Pages: 650–662, Dr. Anne Pick and Prof. Dr. Michael Wiese

    Version of Record online : 22 FEB 2012, DOI: 10.1002/cmdc.201100543

  17. Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 1, July 2008, Pages: 95–103, Y Yamasaki, I Ieiri, H Kusuhara, T Sasaki, M Kimura, H Tabuchi, Y Ando, S Irie, JA Ware, Y Nakai, S Higuchi and Y Sugiyama

    Version of Record online : 2 JAN 2008, DOI: 10.1038/sj.clpt.6100459

  18. You have free access to this content
    Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists

    British Journal of Pharmacology

    Volume 170, Issue 5, November 2013, Pages: 1137–1151, Kenneth K W To and Brian Tomlinson

    Version of Record online : 15 OCT 2013, DOI: 10.1111/bph.12367

  19. You have free access to this content
    ABCG transporters and disease

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3215–3225, Owen M. Woodward, Anna Köttgen and Michael Köttgen

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1742-4658.2011.08171.x

  20. You have free access to this content
    Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytes

    FEBS Letters

    Volume 587, Issue 19, October 01, 2013, Pages: 3202–3209, Yu-Hsing Lin, Hsiao-Min Chang, Fang-Pei Chang, Chia-Rui Shen, Chao-Lin Liu, Wan-Yu Mao, Chung-Chih Lin, Hsuan-Shu Lee and Chia-Ning Shen

    Version of Record online : 14 AUG 2013, DOI: 10.1016/j.febslet.2013.08.011